DK1802746T3 - Virosompartikler indeholdende antigener fra influenzavirus og hepatitis B-virus - Google Patents
Virosompartikler indeholdende antigener fra influenzavirus og hepatitis B-virusInfo
- Publication number
- DK1802746T3 DK1802746T3 DK05795050.3T DK05795050T DK1802746T3 DK 1802746 T3 DK1802746 T3 DK 1802746T3 DK 05795050 T DK05795050 T DK 05795050T DK 1802746 T3 DK1802746 T3 DK 1802746T3
- Authority
- DK
- Denmark
- Prior art keywords
- virosome
- virus
- hepatitis
- particles containing
- containing antigens
- Prior art date
Links
- 239000000277 virosome Substances 0.000 title abstract 6
- 239000002245 particle Substances 0.000 title abstract 2
- 241000700721 Hepatitis B virus Species 0.000 title 1
- 239000000427 antigen Substances 0.000 title 1
- 102000036639 antigens Human genes 0.000 title 1
- 108091007433 antigens Proteins 0.000 title 1
- 241000712461 unidentified influenza virus Species 0.000 title 1
- 101710091045 Envelope protein Proteins 0.000 abstract 2
- 101710188315 Protein X Proteins 0.000 abstract 2
- 102100021696 Syncytin-1 Human genes 0.000 abstract 2
- 241000700605 Viruses Species 0.000 abstract 2
- 238000000034 method Methods 0.000 abstract 2
- 229960005486 vaccine Drugs 0.000 abstract 2
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 208000015181 infectious disease Diseases 0.000 abstract 1
- 150000002632 lipids Chemical class 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 239000012528 membrane Substances 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
- 238000002255 vaccination Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/29—Hepatitis virus
- A61K39/292—Serum hepatitis virus, hepatitis B virus, e.g. Australia antigen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Liposomes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/145—Orthomyxoviridae, e.g. influenza virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/275—Poxviridae, e.g. avipoxvirus
- A61K39/285—Vaccinia virus or variola virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/29—Hepatitis virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5258—Virus-like particles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55555—Liposomes; Vesicles, e.g. nanoparticles; Spheres, e.g. nanospheres; Polymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
- A61K2039/6031—Proteins
- A61K2039/6075—Viral proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2730/00—Reverse transcribing DNA viruses
- C12N2730/00011—Details
- C12N2730/10011—Hepadnaviridae
- C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
- C12N2730/10122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2730/00—Reverse transcribing DNA viruses
- C12N2730/00011—Details
- C12N2730/10011—Hepadnaviridae
- C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
- C12N2730/10134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16023—Virus like particles [VLP]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16041—Use of virus, viral particle or viral elements as a vector
- C12N2760/16043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Virology (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Microbiology (AREA)
- Immunology (AREA)
- Mycology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- Communicable Diseases (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Biochemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- General Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Oncology (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Biophysics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- General Engineering & Computer Science (AREA)
- Pulmonology (AREA)
- Dispersion Chemistry (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicinal Preparation (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP04025573A EP1652914A1 (en) | 2004-10-27 | 2004-10-27 | Virosome particles comprising antigens from influenza virus and Hepatitis B virus |
| PCT/EP2005/011297 WO2006045532A2 (en) | 2004-10-27 | 2005-10-20 | Virosome particles comprising antigens from influenza virus and hepatitis b virus |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1802746T3 true DK1802746T3 (da) | 2011-08-15 |
Family
ID=34927140
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK05795050.3T DK1802746T3 (da) | 2004-10-27 | 2005-10-20 | Virosompartikler indeholdende antigener fra influenzavirus og hepatitis B-virus |
Country Status (12)
| Country | Link |
|---|---|
| EP (1) | EP1652914A1 (da) |
| JP (1) | JP4870085B2 (da) |
| KR (1) | KR101290475B1 (da) |
| CN (1) | CN101048498B (da) |
| AT (1) | ATE508185T1 (da) |
| AU (1) | AU2005298950B2 (da) |
| CA (1) | CA2585309C (da) |
| DE (1) | DE602005027872D1 (da) |
| DK (1) | DK1802746T3 (da) |
| ES (1) | ES2365738T3 (da) |
| NZ (1) | NZ554498A (da) |
| WO (1) | WO2006045532A2 (da) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8697088B2 (en) * | 2007-05-25 | 2014-04-15 | Novavax, Inc. | VLPs derived from cells that do not express a viral matrix or core protein |
| EP2014279A1 (en) * | 2007-06-22 | 2009-01-14 | Pevion Biotech AG | Virosomes comprising hemagglutinin derived from an influenza virus produced in a cell line, compositions, methods of manufacturing, use thereof |
| US20110111459A1 (en) * | 2008-04-18 | 2011-05-12 | The General Hospital Corporation | Compositions and methods for nucleic acid delivery |
| EA016866B1 (ru) * | 2011-06-06 | 2012-08-30 | Общество С Ограниченной Ответственностью "Форт" (Ооо "Форт") | Вакцина для специфической профилактики гриппа |
| CA2960948C (en) * | 2014-09-12 | 2023-04-04 | Bestewil Holding B.V. | Methods for providing adjuvanted virosomes and adjuvanted virosomes obtainable thereby |
| US11020470B2 (en) | 2015-04-13 | 2021-06-01 | The Regents Of The University Of Michigan | Virus-like particles |
| CA3046778A1 (en) | 2016-10-31 | 2018-05-03 | Georgia State University Research Foundation, Inc. | A virus like particle of hepatitis b virus pre-s protein |
| US11523988B2 (en) | 2018-11-29 | 2022-12-13 | Catalent U.K. Swindon Zydis Limited | Oral dispersible vaccine comprising virosomes |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5879685A (en) * | 1991-05-08 | 1999-03-09 | Schweiz, Serum- & Impfinstitut Bern | Immunostimulating and immunopotentiating reconstituted influenza virosomes and vaccines containing them |
| JPH1171303A (ja) * | 1997-08-27 | 1999-03-16 | Rikagaku Kenkyusho | Ｂ型肝炎ワクチン |
| US20030180351A1 (en) * | 1998-11-06 | 2003-09-25 | Reinhard Gluck | Pharmaceutically active composition and dispensing device |
| CU23002A1 (es) * | 2000-12-01 | 2004-11-18 | Ct Ingenieria Genetica Biotech | Método de obtención de agregados antigénicos y su uso en formulaciones |
| CN100488491C (zh) * | 2002-11-21 | 2009-05-20 | 派维翁生物技术有限公司 | 高效融合小泡,其制备方法和含有该小泡的药物组合物 |
-
2004
- 2004-10-27 EP EP04025573A patent/EP1652914A1/en not_active Withdrawn
-
2005
- 2005-10-20 ES ES05795050T patent/ES2365738T3/es active Active
- 2005-10-20 KR KR1020077011890A patent/KR101290475B1/ko active IP Right Grant
- 2005-10-20 NZ NZ554498A patent/NZ554498A/en not_active IP Right Cessation
- 2005-10-20 AT AT05795050T patent/ATE508185T1/de active
- 2005-10-20 DK DK05795050.3T patent/DK1802746T3/da active
- 2005-10-20 CA CA2585309A patent/CA2585309C/en not_active Expired - Fee Related
- 2005-10-20 CN CN2005800371405A patent/CN101048498B/zh not_active Expired - Fee Related
- 2005-10-20 WO PCT/EP2005/011297 patent/WO2006045532A2/en active Application Filing
- 2005-10-20 AU AU2005298950A patent/AU2005298950B2/en not_active Ceased
- 2005-10-20 JP JP2007538311A patent/JP4870085B2/ja not_active Expired - Fee Related
- 2005-10-20 DE DE602005027872T patent/DE602005027872D1/de active Active
Also Published As
| Publication number | Publication date |
|---|---|
| DE602005027872D1 (de) | 2011-06-16 |
| WO2006045532A2 (en) | 2006-05-04 |
| JP2008517961A (ja) | 2008-05-29 |
| CA2585309A1 (en) | 2006-05-04 |
| AU2005298950B2 (en) | 2010-12-16 |
| KR20070095881A (ko) | 2007-10-01 |
| AU2005298950A1 (en) | 2006-05-04 |
| WO2006045532A3 (en) | 2006-08-03 |
| ES2365738T3 (es) | 2011-10-10 |
| JP4870085B2 (ja) | 2012-02-08 |
| NZ554498A (en) | 2009-11-27 |
| CN101048498A (zh) | 2007-10-03 |
| EP1652914A1 (en) | 2006-05-03 |
| CA2585309C (en) | 2016-09-06 |
| KR101290475B1 (ko) | 2013-07-29 |
| CN101048498B (zh) | 2013-02-13 |
| ATE508185T1 (de) | 2011-05-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK1802746T3 (da) | Virosompartikler indeholdende antigener fra influenzavirus og hepatitis B-virus | |
| NO20054608L (no) | Influensavirusvaksine | |
| MX2010003202A (es) | Metodo para producir virus de la gripe. | |
| DE60139026D1 (de) | Lebender influenza impfstoff und verfahren zu seiner herstellung | |
| Ma et al. | Swine influenza vaccines: current status and future perspectives | |
| EA200501890A1 (ru) | Вирусы гриппа высокого титра для приготовления вакцин и генной терапии | |
| ECSP045300A (es) | Antígenos virales | |
| NO20063157L (no) | Influensa-immunogen og vaksine | |
| CN105263516A (zh) | 流感病毒疫苗及其用途 | |
| HK1125674A1 (en) | Rescue of influenza virus | |
| DK1951296T3 (da) | Celleafledte virale vacciner med lave niveauer af restcelle-DNA | |
| JP2004527264A5 (da) | ||
| DK2343084T3 (da) | Funktionelle influenzavirus-lignende partikler (VLP) | |
| DK1216053T3 (da) | Influenzavaccine | |
| EP2708549A3 (en) | Improved vaccines and methods for using the same | |
| MXPA06013411A (es) | Procedimiento para la produccion de una vacuna contra la influenza. | |
| JP2022538693A (ja) | タンパク質加水分解標的ウイルス、その生ワクチン及びその作製方法と用途 | |
| NO20090177L (no) | Vaksiner for malaria | |
| WO2008085147A3 (en) | Novel plant virus particles and methods of inactivation thereof | |
| ATE547116T1 (de) | Kombinationsimpfstoff | |
| CY1118741T1 (el) | Αναπνευστικος συγκυτιακος ιος με μια γονιδιωματικη ατελεια συμπληρωμενη in trans | |
| WO2011153351A3 (en) | Novel modified live-attenuated vaccines (mlv) and subunit vaccines created by dna shuffling against porcine reproductive and respiratory syndrome virus (prrsv) | |
| EP2368576A3 (en) | Functionally reconstituted viral membranes containing adjuvant | |
| EP1497468A4 (en) | CELLS FOR DETECTION OF INFLUENZA AND INFLUENZA VIRUSES | |
| DK1383795T3 (da) | Rekombinant nucleoproteinmutant fra Newcastle disease-virus som markörvaccine |